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Abstract
Background: In sepsis syndromes the severity of the inflammation triggers microvascular dysfunction and early
organ failure. We studied the effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculatory
integrity in an endotoxinemic rat model.
Methods: In both control and endotoxinemic (5 mg/kg lipopolysaccharide i.v.) rats, the effect of cervical bilateral
vagotomy with or without left-sided distal vagus nerve stimulation were compared to non-vagotomized,
nonstimulated group (sham). Neurovascular coupling was analyzed by electrical forepaw stimulation, EEG, and
cortical laser-Doppler flow recording. Resting cerebral blood flow, evoked potentials and hemodynamic responses,
were obtained over a period of 4.5 hours. Regulation of the nitric oxide system (iNOS expression and nitrite/nitrate
measurements), cytokines (IFN-γ, TNF-α, IL-6, IL-10), hypoxic and apoptosis signaling molecules (HIF-2α, Bax) were
measured at the end of experiments.
Results: In endotoxinemic rats, vagus nerve stimulation tended to increase anti-inflammatory cytokine levels
and resulted in a stabile hemodynamic response (28 ± 13%; versus baseline). Vagotomized animals incurred a
pro-inflammatory response (7 ± 4%; P< 0.0001 versus baseline) and produced more HIF-2α than vagotomized
vagus nerve stimulated (VNS) animals. Evoked potential amplitudes were stabilized in VNS (15 ± 7 μV; n.s.
versus baseline) as compared to vagotomised rats (8 ± 5 μV; P< 0.001 versus baseline). However, no effects
were observed on apoptosis markers or nitric oxide levels.
Conclusions: Vagus nerve stimulation in endotoxinemic rats had a positive effect on neurovascular coupling
and stabilized evoked potentials.
Keywords: Microcirculation, Brain, Neurovascular coupling, Evoked potentials, Hypoxia, Sepsis, Inflammation,
Lipopolysaccharide, EEG, Vagus nerve stimulation
Background
Sepsis is the most frequent cause of death in intensive
care units (ICUs). In industrialized countries, it has an
average incidence of 300/100,000 per year, increasing sig-
nificantly in the elderly [1,2]. Despite many improvements
in the therapy of ICU patients, mortality from sepsis
remains high. Each year, in the United States alone,
approximately 600,000 patients develop sepsis; resulting
in the death of approximately 240,000 people [3].
Sepsis is increasingly recognized as an acute disease
process as treatment during the first six to twenty-four
hours is critical for patient survival [4]. The brain is one
of the first organ systems affected by sepsis. A sepsis-
associated delirium occurs in 30% to 70% of cases, often
preceding other signs of sepsis [5,6]. Neurovascoular
coupling (NVC) adapts blood–brain circulation in ac-
cordance with blood–brain demands. NVC, therefore,
adapts to disturbances in metabolically driven blood
flow, which leads to changes in neurofunctional
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parameters [7]. In addition to cytokine storms, nitric
oxide (NO) production by inducible nitric oxide syn-
thase (iNOS) is generally assumed to play an important
role in early microcirculatory failure, which triggers fur-
ther organ dysfunction [7-13].
Distal vagus nerve stimulation (VNS) was shown to
mitigate the inflammatory response and thereby improve
survival in a variety of animal sepsis models [14,15]. An
inhibition of the inflammatory response reduces cyto-
kine levels and lowers the induction of the iNOS [16].
Inhibition of iNOS by the specific inhibitor 1400W
improved microvascular function in the brain in endo-
toxinemic rats [8]. However, possible effects on the nitric
oxide system, and therefore microcirculatory function-
ing, have not been investigated under VNS.
In this study, we investigated the role of distal VNS
versus vagotomy (VGX) on the integrity of the NVC in
the brain of endotoxinemic rats by laser Doppler flow-
metry (LDF). We also monitored the effects that VNS
had on cytokines, apoptosis, hypoxia, and the NO sys-
tem. To assess possible nonspecific effects of either VNS
or VGX on NVC, corresponding experiments were per-
formed on nonseptic rats.
Methods
All animal experiments were performed in strict accord-
ance with the National Institutes of Health Guide for
Care and Use of Laboratory Animals and approved by
the local Animal Care and Use Committee of the
‘Regierungspräsidium’ Giessen, Hessen, Germany.
General preparation
Adult male Sprague Dawley rats (290 to 320 g) were
purchased from Harlan Laboratories (Harlan, Rossdorf,
Germany). They were housed five to a cage with food
and water available ad libitum and were maintained on
a 12-hour light/dark cycle (lights on at 07:00). For the
experiments, rats were initially anesthetized with isoflur-
ane, tracheotomized, paralyzed with pancuronium brom-
ide (0.2 mg/kg/h) and mechanically ventilated (Harvard
Rodent Ventilator; Harvard Apparatus, South Natick,
MA, USA). The right femoral artery and vein were can-
nulated for blood pressure recording, blood sampling,
and drug administration. Rectal body temperature was
maintained at 37°C using a feedback-controlled heating
pad.
Isoflurane anesthesia was discontinued and replaced by
an intravenous application of α-chloralose (80 mg/kg;
Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) for
a period of 60 minutes to washout isoflurane. α-chloralose
anesthesia was continued for the duration of the experi-
ment. Supplementary doses of chloralose (30 mg/kg) were
given every hour. During chloralose anesthesia, the ani-
mals were ventilated with a 1:1 mixture of nitrogen and
oxygen. Arterial blood gas analyses and pH were mea-
sured repeatedly at least every 30 minutes (blood gas
analyzer model Rapidlab 348; Bayer Vital GmbH, Fern-
wald, Germany). Glucose and lactate levels were mea-
sured simultaneously (Glukometer Elite XL, Bayer Vital
GmbH, Fernwald, Germany; Lactate pro, Arkray Inc.
European Office, Düsseldorf, Germany), while glucose
concentrations were maintained at> 60 mg/dl. A moder-
ate volume therapy of 1.2 ml/hour of 0.9% NaCl was
given to replace renal and perspirative fluid losses.
Neurovascular coupling measurements
The head of each animal was fixed in a stereotaxic frame
without perforating the tympanum. The apex of the skull
was exposed, and the bone over the left parietal cortex
was thinned with a saline-cooled drill to allow transcra-
nial laser Doppler flowmetry (LDF). The laser probe
(BRL-100; Harvard Apparatus, South Natick, MA, USA)
was placed 3.5 mm lateral and 1 mm rostral to the
bregma in accordance with the coordinates of the som-
atosensory cortex, a location that corresponds closely to
the region of maximal hemodynamic response during
contralateral forepaw stimulation. The laser Doppler sig-
nal and the systemic mean arterial blood pressure were
recorded continuously and processed on a personal com-
puter running data acquisition software (Neurodyn; HSE,
March-Hugstetten, Germany). Since the laser Doppler
measures flow changes rather than absolute values, rest-
ing LDF signals had arbitrary units. However, evoked sig-
nal changes were used to assess flow changes, which are
given in percentage changes from the baseline.
Brain electrical activity was recorded monopolarily
with an active calomel electrode placed 0.5 mm behind
the laser probe and an indifferent calomel electrode
placed on the nasal bone. Signals were recorded and
amplified (BPA Module 675; HSE, March-Hugstetten,
Germany) and somatosensory evoked potentials (SEP)
were averaged using the Neurodyn acquisition software
(HSE, March-Hugstetten, Germany).
Somatosensory stimulation was achieved with electrical
pulses applied by small needle electrodes inserted under
the skin of the right forepaw (PSM Module 676; HSE,
March-Hugstetten, Germany). The pulses consisted of
rectangular bipolar pulses of 1.5 mA and a pulse width of
0.3 ms. The pulse repetition frequency was set at 2 Hz
and stimulations were carried out for 30 seconds. Stimu-
lation with 1.5 mA ensured that pain fibers were un-
affected, thereby preventing changes in blood pressure. A
rest of 30 seconds followed each stimulation train while
activation rest cycles were repeated 10 times in order to
increase the signal to noise ratio.
Flow velocity responses were averaged and calculated
relative to the resting phase, which was set to zero. The
evoked flow velocity responses (EFVR) were calculated
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from the averaged relative flow velocity signals under
conditions of stimulation.
Evoked potential amplitudes were calculated from the
N2-P1 amplitude differences and the latency between
the beginning of stimulation and the occurrence of the
P1 peak was examined.
Vagus nerve stimulation
The nervus vagus of each side was exposed at the cervical
level lateral of the trachea running in parallel with the
common carotid artery. Both vagus nerves were carefully
dissected from their artery in each rat. The right vagus
nerve mainly innervates the thoracic organs such as the
lung and heart, whereas the left trunk mainly innervates
the intestinal organs and the plexus mesentericus. For
vagus nerve stimulation, the left nerve was cut. The distal
part of the nerve was then fixed in a special nerve stimu-
lation clamp (HSE, March-Hugstetten, Germany) to allow
electrical stimulation of the distal trunk of the vagus
nerve. To exclude aberrant innervations of the intestinal
organs from the right nervus vagus, this nerve was also
cut. Electrical pulses of 2 mA were applied during a
0.3 ms pulse width, and 2 Hz repetition frequency for a
period of 10 minutes [15]. Stimulation blocks were
repeated every 45 minutes, starting before the applica-
tion of endotoxin and continuing until the end of
experimentation (4.5 hours). Additional experiments were
performed to measure neurovascular coupling (Figure 1).
Study design
In random order, 60 rats received 5 mg/kg body weight
intravenous lipopolysaccharide (LPS, from Escherichia
coli, O111:B4; Sigma-Aldrich Chemie GmbH, Germany)
or 0.5 ml of 0.9% NaCl. LPS was dissolved in 0.5 ml of
0.9% NaCl and slowly administered for 5 minutes. Endo-
toxinemic and sham groups were further divided into
three subgroups. In one subgroup, bilateral cervical va-
gotomy (VGX) was performed without stimulation of
the nerve (LPS group: VGX LPS; nonseptic group:
VGX). In a second group, the distal trunk of the left
vagus nerve was stimulated after bilateral cervical vagot-
omy (LPS group: VGX LPS + STIM; sham group: VGX+
STIM). In a third group, the operation of the vagus
nerve was stopped before vagotomy and the vagus nerve
was not stimulated (LPS group: SHAM LPS; nonseptic
group: SHAM). Each experimental group consisted of 10
animals. Experiments were performed up to 4.5 hours
after LPS/vehicle administration since previous studies
have shown that blood pressure levels remain above the
lower limit of the cerebral autoregulation during this
time period [7,8], thus excluding secondary ischemic
brain damage due to a decline in systemic blood
Figure 1 Illustration of the preparation period and experimental protocol together with time points of vagal interaction or
neurofunctional measurements.
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pressure. Plasma samples were obtained before the rats
were killed. Brains were removed and stored at −80°C.
Biochemical determination of the effects of VNS or VGX
on inflammatory parameters
The following experiments were carried out on the endo-
toxinemic groups (SHAM LPS, VGX LPS, VGX LPS+
STIM) and the non-treated control group (SHAM).
Immunoblotting
Rat cortex tissues obtained from three animals from
each group were lysed in RIPA buffer containing
Na3VO4, protease inhibitors, and PMSF. The lysates
were resolved with SDS-PAGE (10% acrylamide) and
transferred onto nitrocellulose membranes, blocked for
one hour in 5% non-fat milk at room temperature and
probed with the appropriate primary antibody overnight
at 4°C at the following dilutions: β-actin (Abcam plc,
Cambridge, United Kingdom; ab6276,1:3000), iNOS
(Santa Cruz Biotechnology, Heidelberg, Germany; iNOS
(M-19) sc-650,1:800), HIF-2α (Novus Biologicals, Cam-
bridge, United Kingdom; NB100-132,1:500). After over-
night incubation in primary antibody, membranes were
washed with wash buffer and incubated with the respect-
ive horseradish peroxidase-conjugated polyclonal sec-
ondary antibodies for one hour at room temperature
(RT). After washing, the blots were developed with an
enhanced chemiluminescence (ECL) kit (GE Healthcare
Europe GmbH, Freiburg, Germany) followed by film ex-
posure. The reported optical densities are the means and
SEMs of three separate experiments.
RNA isolation, real-time PCR (RT-PCR), and quantitative
real-time PCR (qRT-PCR)
Total RNA was extracted from frozen rat cortex tissue
using Trizol reagent (Invitrogen, Carlsbad, CA, USA) fol-
lowing the manufacturer’s protocols. Each group con-
sisted of n = 6 rats. cDNA synthesis was performed with
the ImProm-II™ Reverse Transcription System (Promega,
Madison, WI, USA) by incubating 0.8 μg of RNA accord-
ing to the manufacturer’s instructions. qRT-PCR was per-
formed with 2 μl cDNA. The oligonucleotide primer pairs
(rat origin) were as follows: rat porphobilinogen deami-
nase (PBGD) 5′-CAAGGTTTTCAGCATCGCTACCA-
3′ (forward) and 5′-ATGTCCGGTAACGGCGGC-3′
(reverse); rat inducible nitric oxide synthase (iNOS)
5′-CAGCCACCTTGGTGAGGGGA-3′ (forward) and
5′- TCCAGGGGCAAGCCATGTCT-3′ (reverse); rat
Bcl-2-associated X protein (BAX) 5′-CAAGAAGCT-
GAGCGAGTGTCT -3′ (forward) and 5′-CAAT-
CATCCTCTGCAGCTCCATATT-3′ (reverse).
qRT-PCR was carried out in a Stratagene Mx3000P™
qPCR system (Stratagene, La Jolla, CA, USA) and data
were analyzed with accompanying software. The cycling
protocol was as follows: polymerase activation, 95°C for
10 minutes; 40 cycles with denaturation at 95°C for 30
seconds, annealing at 58°C for 30 seconds and extension
at 72°C for 30 seconds. To ensure that a single, specific
product was generated, dissociation curves were evalu-
ated. Relative expression levels were calculated as ΔCt
values by normalizing Ct values of target genes to Ct
values of PBGD as previously described. For every gene
we performed three independent measurements. All data
reported are the means and SEM of three separate
experiments.
Cytokine ELISA
Following the experiments, blood samples were drawn
into tubes containing heparin sodium 2500 (Ratiopharm,
Ulm, Germany). They were immediately centrifuged and
separated, and the plasma stored at −80°C until analysis.
Cytokine determinations for IFN-γ, TNF-α, IL-6, IL-10
concentrations in plasma samples were performed with
ELISA sets (BD Bioscience, Heidelberg, Germany) for
each LPS group (n = 6) as well as for the SHAM group.
Measurement of NO concentration in plasma samples
NO metabolite (nitrite and nitrate) concentrations were
determined for each of 10 samples in the sepsis groups
and in the SHAM group using NOA Sievers 280 (FMI
GmbH, Seeheim, Germany) according to the manufac-
turer’s instructions. Briefly, plasma samples were drawn
4.5 hours after LPS injection into heparin-containing
tubes, immediately centrifuged, and stored at −20°C until
measurements were taken. NO reaction products in sam-
ples were reduced by vanadium chloride. Resulting gas-
eous NO was detected by NOA Sievers 280, which was
connected to a computer for data transfer and analysis by
NOAWIN 32 software (DeMeTec, Langgöns, Germany).
Statistical evaluation of physiological data
Statistical analyses were performed with a two-way
ANOVA with the factors within and between groups to
assess differences between the groups. In cases of signifi-
cance, a Scheffe’s post hoc test was applied. For intergroup
comparisons the statistical analyses were performed
against baseline measurements. If the assumptions of nor-
mal distribution and equality of variances could not be
assured in the statistic F-test, a nonparametric paired-sign
or Kolmogorov-Smirnov test was conducted (Statview,




The SHAM group exhibited stable blood gas,
hemodynamic and neurofunctional parameters through-
out the study (Tables 1 and 2). The higher pH at baseline
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Table 1 Group averaged data for glucose, lactate, pH, pC02 and hemoglobin
Glucose (mg/dl) Lactate (mmol/l) pH p02(mmHg) pC02 (mmHg) Hemoglobin (g/l)
Baseline End Baseline End Baseline End Baseline End Baseline End Baseline End
SHAM 63 ± 8 84 ± 21 0.8 ± 0.05 0.9 ± 0.1 7.49 ± 0.06 7.47 ± 0.03 250± 18 246 ± 29 36 ± 3 38± 4 140± 10 120 ± 20**
VGX 98 ± 30 98 ± 18 0.8 ± 0.03 0.9 ± 0.1 7.45 ± 0.05 7.50 ± 0.06 265± 19 250 ± 23 41 ± 8 33± 4 140± 10 130 ± 10*
VGX+ STIM 71 ± 15 105 ± 49 0.9 ± 0.2 1.3 ± 0.5 7.52 ± 0.06 7.51 ± 0.04 259± 19 248 ± 5 37± 5 36± 5 130± 10 100 ± 20*
SHAM LPS 65 ± 13 69 ± 26 0.8 ± 0.1 1.9 ± 0.5s 7.47 ± 0.05 7.45 ± 0.03 250± 14 233 ± 30 40 ± 4 35± 3* 150± 10 120 ± 10 s
VGX LPS 82 ± 22 129 ± 90 0.8 ± 0.1 2.2 ± 0.7s 7.45 ± 0.07 7.37 ± 0.08** 272± 13 249 ± 26 41 ± 6 39± 4 150± 10 120 ± 20**
VGX LPS+ STIM 85 ± 25 65 ± 20 0.9 ± 0.1 1.8 ± 0.6*** 7.48 ± 0.4 7.43 ± 0.1 251± 22 233 ± 21 38 ± 2 35± 5 130± 10 100 ± 20***
Data are given as the mean ± standard deviation (SD) together with statistical differences. Significance is given as: *, P< 0.05; **, P< 0.01; ***, P< 0.001; s,
P< 0.0001 compared with baseline. LPS, lipopolysaccharide; pC02, partial pressure of carbon dioxide; SHAM, sham surgery; VGX, bilateral vagotomy;
VGX+ STIM, bilateral vagotomy and distal vagus nerve stimulation.
Table 2 Group averaged data for mean blood pressure, somatosensory evoked potentials, P1 latencies, evoked flow
velocity responses and resting LDF signal at different time points of the experiment
Baseline 30 min 60 min 120 min 180 min 240 min 270 min
Mean BP (mmHg) SHAM 116± 20 120 ± 12 108± 20 113 ± 14 114± 19 108 ± 20 108 ± 20
Mean BP (mmHg) VGX 115± 13 110 ± 13 112± 19 109 ± 14 110± 17 115 ± 22 115 ± 22
Mean BP (mmHg) VGX+ STIM 109± 10 99 ± 14 103± 18 100 ± 23 104± 29 93 ± 21 93 ± 21
Mean BP (mmHg) SHAM LPS 123± 11 118 ± 14 106± 15** 104 ± 10** 90 ± 12s 90 ± 18s 90 ± 18s
Mean BP (mmHg) VGX LPS 117± 9 109 ± 17 91 ± 17s 94 ± 18*** 101± 13* 97 ± 10** 97 ± 10**
Mean BP (mmHg) VGX LPS + STIM 119± 13 114 ± 12 94 ± 17* 92 ± 7*** 86 ± 20 s 90 ± 14*** 90 ± 14***
SEP (μV) SHAM 13± 7 15± 6 14± 4 15± 5 14± 5 15± 5 14 ± 5
SEP (μV) VGX 15± 9 15± 8 16± 9 16± 9 15± 6 15± 6 16 ± 8
SEP (μV) VGX+ STIM 15± 9 13± 4 14± 4 12± 5 11± 5 13± 3 15 ± 8
SEP (μV) SHAM LPS 17 ± 5 16± 6 15± 6 12± 6 11± 5 11± 4** 10 ± 6**
SEP (μV) VGX LPS 18 ± 6 15± 4 14± 5 12± 4** 11 ± 7** 10 ± 5** 8 ± 5***
SEP (μV) VGX LPS + STIM 18± 8 18± 9 19± 9 16± 5 16± 5 14± 4 15 ± 7
P1 latency (ms) SHAM 10.8 ± 1 11.1 ± 1 11.2 ± 1 11.1 ± 1 11.3 ± 1 11.4 ± 1 11.7 ± 2
P1 latency (ms) VGX 10± 0.6 10 ± 0.5 10 ± 0.6 10 ± 0.4 10 ± 0.4 10 ± 0.4 10.1 ± 0.5
P1 latency (ms) VGX+ STIM 10.2 ± 1 10.4 ± 1 10.5 ± 1 10.3 ± 1 10 ± 0.7 10 ± 0.7 10 ± 0.9
P1 latency (ms) SHAM LPS 10 ± 0.5 10 ± 0.6 10 ± 0.5 10 ± 0.6 10 ± 0.6 10.3 ± 0.7 10.4 ± 1
P1 latency (ms) VGX LPS 10 ± 0.8 10.4 ± 1 10.4 ± 0.8 10.6 ± 0.4 10.6 ± 0.7 11 ± 0.9 11 ± 1
P1 latency (ms) VGX LPS + STIM 10± 0.4 10 ± 0.3 10 ± 0.3 10 ± 0.3 10 ± 0.4 10.2 ± 0.4 10 ± 0.4
EFVR (%) SHAM 34± 10 26 ± 7 30± 11 31 ± 15 29 ± 14 31 ± 12 28 ± 7
EFVR (%) VGX 23± 13 23 ± 15 21 ± 11 24 ± 15 24 ± 6 23± 7 24 ± 11
EFVR (%) VGX+ STIM 33± 13 35 ± 18 36 ± 13 29 ± 17 31 ± 18 32 ± 25 38 ± 14
EFVR (%) SHAM LPS 27 ± 11 29 ± 11 26 ± 8 18± 10 18 ± 16 14 ± 11* 12 ± 8*
EFVR (%) VGX LPS 34 ± 9 36± 7 26± 5 19± 9** 17 ± 16** 7 ± 5s 7 ± 4s
EFVR (%) VGX LPS + STIM 34± 8 35± 11 32 ± 9 31± 13 28 ± 12 29 ± 13 28 ± 13
Resting LDF (U) SHAM 163± 66 152 ± 71 140± 62 145 ± 82 142± 75 145 ± 71 139 ± 72
Resting LDF (U) VGX 233± 78 219 ± 106 211± 88 199 ± 84 203± 101 213 ± 111 201 ± 107
Resting LDF (U) VGX+ STIM 224± 92 231 ± 75 232± 60 239 ± 30 193± 33 196 ± 49 186 ± 57
Resting LDF (U) SHAM LPS 202± 56 198 ± 64 186± 64 189 ± 72 204± 96 215 ± 104 250 ± 105
Resting LDF (U) VGX LPS 160± 70 141 ± 58 151± 62 157 ± 57 192± 60 198 ± 67 196 ± 59
Resting LDF (U) VGX LPS + STIM 173± 68 165 ± 69 177± 69 185 ± 65 227± 35 231 ± 56 227 ± 52
Data are given as the mean ± standard deviation (SD) together with statistical differences. Significance is given as: *, P< 0.05; **, P< 0.01; ***, P< 0.001; s,
P< 0.0001 compared to baseline. BP, blood pressure; EFVR, evoked flow velocity responses; LDF, laser Doppler flowmetry; LPS, lipopolysaccharide;
SEP, somatosensory evoked potentials; SHAM, sham surgery; VGX, bilateral vagotomy; VGX + STIM, bilateral vagotomy and distal vagus nerve stimulation.
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was related to the α-chloralose which leads to a well-
known metabolic alkalosis. Due to the administration vol-
ume there was a significant decrease in the hemoglobin
concentration at the end of the study as compared to the
baseline (140 ± 10 g/l versus120± 20 g/l; P< 0.001).
LPS-treated animals developed signs of a moderate
sepsis-like syndrome with typical changes in blood pres-
sure (SHAM LPS: baseline 123 ± 11 mmHg versus
90 ± 18 mmHg, P< 0.0001), pH-level (SHAM LPS: base-
line 7.47 ± 0.05 versus 7.45 ± 0.03), lactate concentrations
(SHAM LPS: baseline 0.8 ± 0.1 mmol/l versus 1.9 ± 0.5
mmol/l, P< 0.0001). The data are given in the tables as
follows: Table 1 illustrates the group averaged data for
glucose, lactate, and pH, partial pressure of oxygen and
carbon dioxide as well as hemoglobin content, which
was obtained at baseline conditions (baseline) and at the
end of the experiment (end). Table 2 shows the group
data for mean blood pressure together with N2-P1 po-
tential amplitude, P1 latency, the evoked flow velocity
response and resting LDF signal. The cytokines TNF-α,
IFN-γ, IL-10, and IL-6 are given in Figure 2.
Vagal effects in nonseptic rats
In non-endotoxinemic groups, VGX and VNS (VGX+
STIM) did not significantly change blood gas,
hemodynamic or neurofunctional parameters as com-
pared to the baseline (Tables 1 and 2). Stimulation of the
left nervus vagus did not induce a significant decrease in
blood pressure. Due to the administration volume of sa-
line, hemoglobin levels decreased moderately until the
end of experiments in each group (140 ± 10 g/l ver-
sus130 ± 10 g/l and 130 ± 10 g/l versus100 ± 20 g/l, re-
spectively, both P< 0.05; Tables 1 and 2).
Vagal effects in endotoxinemic rats
Although the changes in hemodynamic and cytokine
levels were statistically insignificant between groups, the
VNS group tended to mitigate the inflammatory
Figure 2 Cytokine concentrations in plasma samples 4.5 hours after lipopolysaccharide (LPS) administration for all LPS groups and the
control (SHAM, white bar) group. (A) TNF-α, (B) IFN-γ, (C) IL-6, and (D) IL-10 levels measured by ELISA. In all groups, a significant increase
occurs under septic conditions. Although vagus nerve stimulation (VGX LPS + STIM; black bar) appears to have an anti-inflammatory action, while
vagotomy (VGX, gray bar) has a proinflammatory action, statistical examinations between the groups were insignificant. Statistical differences
versus SHAM are given as *, P< 0.05; **, P< 0.01; ***, P< 0.001; n = 6 rats each. Data are given as the mean± SEM.
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response whereas VGX rats showed a trend toward an
increase in inflammatory response. Data for the blood
gas analysis, hemodynamic and neurofunctional para-
meters are given in Tables 1 and 2. VNS or VGX did not
have a significant effect on changes in the mean arterial
blood pressure (mean BP, Figure 3A) or resting laser
Doppler signal (resting LDF, Figure 3D). Both somato-
sensory evoked potential amplitudes (SEP, Figure 3B)
and evoked flow velocity responses (EFVR, Figure 3C),
were stabilized under VNS and decreased in VGX
(Table 2). In the SHAM LPS group EFVR significantly
declined 240 minutes after LPS application with the
smallest responses at the end of the experiments (SHAM
LPS: 4.5 hours: 12 ± 8% versus baseline: 27 ± 11%;
P= 0.05). On the one hand, a stronger and earlier (120
minutes) lowering of EFVR was seen in the VGX LPS
group (VGX LPS: 4.5 hours: 7 ± 4% versus baseline:
34 ± 9%; P< 0.0001). On the other hand, VNS stabilized
hemodynamic responses throughout the study (VGX
LPS + STIM: 4.5 hours: 28 ± 13% versus baseline:
34 ± 8%; P=n.s.). Similarly, VNS stabilized evoked poten-
tial amplitudes under inflammatory conditions (VGX
LPS + STIM: 4.5 hours: 15 ± 7 μV versus baseline: 18 ± 8
μV; P=n.s.) whereas the SHAM LPS group showed a
significant decline (SHAM LPS: 4.5 hours: 10 ± 6 μV ver-
sus baseline: 17 ± 5 μV; P< 0.01). The first significant
drop compared to the baseline occurred 240 minutes
after LPS application in the SHAM LPS group (Table 2).
Again, the VGX LPS group showed a stronger and earl-
ier (120 minutes) significant decline in potential ampli-
tudes (VGX LPS: 4.5 hours: 8 ± 5 μV versus baseline:
18 ± 6 μV; P< 0.001). The P1 latencies did not differ
with time or between groups (Table 2). The occurrence
of cerebral hyperaemia as concluded from the resting
flow velocity recordings was approximately 30% among
all (Table 2). Comparing the VGX LPS and VGX LPS +
STIM group at each time point, we found a significant
Figure 3 Data for mean arterial blood pressure (BP, (A)),
somatosensory evoked potential amplitudes (SEP, (B)), evoked
hemodynamic responses (EVFR, (C)), and resting laser Doppler
flow values (resting LDF, (D)) are given for the
lipopolysaccharide (LPS)-treated groups. There were no
significant differences for the BP and resting LDF between the
groups. The resting LDF increased approximately 30% until the end
of experiments. Vagus nerve stimulation stabilized potential
amplitudes (VGX LPS + STIM; * P< 0.05 versus SHAM LPS, graph B)
whereas vagotomy had an opposite effect (VGX LPS) as compared
to the sham surgeries (SHAM LPS). The evoked responses remained
stable throughout the experiments in the VGX LPS + STIM group
showing a significant difference to the SHAM LPS group (*, P< 0.05,
VGX LPS + STIM versus SHAM LPS, graph C). Again, vagotomy had a
negative effect on the uncoupling (#, P< 0.05, VGX versus VGX
LPS + STIM, ##, P< 0.01, VGX versus VGX LPS + STIM, graph C). n = 10
rats each. Data are given as the mean± SEM.
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difference in the EFVR after 180 minutes, whereas the
SEP amplitudes first differentiated at 4.5 hours. These
data indicate that uncoupling precedes changes in
evoked potentials. Similarly, comparing the VGX LPS +
STIM and the SHAM LPS groups a significant decline
in EFVR in the SHAM LPS group occurred at 4.5 hours,
while the potential amplitudes did not differ between the
groups at this time point.
Vagal effects on NO-hypoxia and apoptosis signaling in
septic rats
HIF-2α increased significantly (P< 0.05) in the VGX
LPS group compared to the SHAM group; no significant
changes were found in other LPS groups (Figure 4). Al-
though there were no major differences of iNOS mRNA
expression within the LPS groups, there was a significant
increase in protein and nitrite/nitrate levels (Figure 5).
Interestingly, nitrite/nitrate levels were significantly
lower in the VGX LPS group than in other LPS groups
(Figure 5). mRNA for the apoptosis signaling molecule
BAX did not differ between any groups (Figure 6).
Discussion
In this study, we demonstrate for the first time that VNS
prevented early microvascular dysfunction in the brain
of LPS-challenged rats. In contrast, VGX led to an
earlier and more pronounced decline in hemodynamic
responses. Furthermore, evoked potential amplitudes in
VNS animals resulted in a significant protective effect as
compared to VGX after 4.5 hours. We speculate that
these protective effects might be linked to the anti-
inflammatory property of VNS. Conversely, it was shown
that increased endotoxin doses resulted in a more severe
uncoupling of the NVC relative to the severity of the in-
flammatory responses [12].
In order to standardize the initial inflammatory re-
sponse, we chose an intravenous endotoxin model rather
than a cecal ligation and puncture model. This issue is
crucial in the present study in which the acute changes
in evoked potentials and evoked hemodynamic
responses were addressed. Furthermore, as animals need
no further surgical manipulation, neurophysiological
monitoring from stable LDF and electrode positions is
guaranteed, enabling a direct, standardized comparison
between baseline and inflammatory conditions.
Apoptotic signaling pathways are known to be induced
during later phases of sepsis. For example, it has been
shown that protein-levels of Bax- and Bcl-related pro-
and anti-apoptotic pathways are not induced until eight
hours after sepsis induction, with changes in histology
only present after twenty-four hours [17]. To confirm
our delayed responses we investigated the pro-apoptotic
Figure 4 Western blot analysis and quantification of HIF-2α expression in the cortex 4.5 hours after lipopolysaccharide (LPS)
administration for all LPS groups and the control group (SHAM, white bar). With the exception of the vagotomy group (VGX LPS, gray
bar), no significant differences to the SHAM group were found in the LPS-treated and sham-operated (SHAM+ LPS, light gray bar) or vagus
nerve-stimulated groups (VGX LPS + STIM, black bar). The significant increase in the VGX LPS (gray bar) group is an indicator of a hypoxic
condition; * P< 0.05 compared to SHAM; n = 6 rats each. Data are given as the mean± SEM.
Mihaylova et al. Journal of Neuroinflammation 2012, 9:183 Page 8 of 11
http://www.jneuroinflammation.com/content/9/1/183
protein Bax at the RNA-level and also did not find a sig-
nificant change at this early stage.
In contrast to our initial hypothesis, the positive effect
on neurovascular coupling cannot be explained by a
modification of the NO pathway. The nitrite/nitrate con-
centrations, as well as the transcription of the iNOS
gene, were not affected by VNS. Also, the macrocircula-
tory parameters did not show typical effects of iNOS in-
hibition such as an increased blood pressure or
prevention of cerebral hyperemia [8]. Moreover, the
enzyme levels of iNOS were induced rather than low-
ered in VNS animals. Although a similar VNS effect
was found in the ischemic heart, this issue needs fur-
ther exploration [18].
Reduced nitrite/nitrate concentrations in the VGX
group were unexpected given the pro-inflammatory ac-
tion of VGX and the increased protein levels of iNOS.
Figure 5 Real-time PCR iNOS mRNA expression (graph A) and
western blot analysis and protein quantification of iNOS
expression (graph B) in the cortex 4.5 hours after
lipopolysaccharide (LPS) administration for all LPS groups and
the control group (SHAM, white bar). Graph C shows the results
of the plasma nitrate/nitrite quantification from samples taken 4.5
hours after LPS administration. Besides a significant increase in the
mRNA expression in all LPS groups (*, P< 0.05; **, P< 0.01 versus
SHAM, graph A), there were no differences comparing the
vagotomy (VGX LPS, gray bar), LPS-treated and sham-operated
(SHAM+ LPS, light gray bar) or vagus nerve-stimulated (VGX
LPS + STIM, black bar) groups (n = 6 rats). All LPS groups showed a
significant increase in iNOS protein compared to SHAM. Within the
LPS groups vagotomy (VGX LPS, gray bar) and vagus nerve
stimulation (VGX LPS + STIM, black bar) led to a further significant
increase compared to SHAM LPS (light gray bar). **, P< 0.01, ***,
P< 0.001 compared to SHAM; #, P< 0.01 VGX LPS + STIM versus
SHAM LPS; $, P< 0.001 VGX LPS + STIM versus SHAM LPS. n = 3 rats
each. Nitrite/nitrate significantly increased in all LPS groups
compared to SHAM. Compared to SHAM LPS (light gray bar) and
vagus nerve stimulation (VGX LPS + STIM) the VGX LPS (gray bar)
group showed significant lower values. ***, P< 0.001 compared to
SHAM; #, P< 0.001 compared to SHAM. n = 10 rats each. Data are
given as the mean± SEM.
Figure 6 Real-time PCR BAX mRNA expression in the cortex 4.5
hours after lipopolysaccharide (LPS) administration for all LPS
groups and the control group (SHAM, white bar). Compared to
SHAM LPS groups did not show any differences. LPS groups with
vagotomy (VGX LPS, gray bar), sham operation (SHAM+ LPS, light
gray bar) or vagus nerve stimulation (VGX LPS + STIM, black bar) also
did not show differences. n = 6 rats each. Data are given as the
mean± SEM.
Mihaylova et al. Journal of Neuroinflammation 2012, 9:183 Page 9 of 11
http://www.jneuroinflammation.com/content/9/1/183
Le Cras and McMurty suggested that oxygen substrate
limitation may regulate NO production under hypoxic
conditions [19]. High altitude-induced pulmonary hyper-
tension is caused by reduced NO production due to a
drop in the pO2 tension [20]. In stroke models, reduced
NOS activity was found in the hypoxic tissue of the pen-
umbra [21]. The dissociation of the microcirculation in
areas of hyper- and hypoperfusion and the fluctuation
between states hampers direct measurement of oxygen
tension in the microcirculation [22]. Taken together, the
strong depression of NVC, increased HIF-2α levels, and
reduced nitrite/nitrate concentrations are likely due to
the brains hypoxic state under VGX. HIF-2α serves as a
hypoxia marker under inflammatory conditions since it
is not affected by the inflammation itself, such as HIF-
1α [23]. Further support of ischemic conditions in the
brain during sepsis comes from MRT investigations
demonstrating signs of microinfarcts in early phases of
sepsis [24]. Sepsis survivors display typical changes in
the brain mimicking a hypoxic condition, and are clinic-
ally similar to patients who underwent cardiac resuscita-
tion or suffered carbon monoxide intoxication [25-27].
The notion of a local, rather than a general, hypoxic
condition in the septic VGX group is supported by blood
gas and blood pressure data, which indicate sufficient
macrocirculatory and pulmonary functioning.
Conclusions
Microvascular dysfunction plays an important role in
the occurrence of early organ dysfunction in sepsis syn-
dromes. By its anti-inflammatory action, VNS stabilizes
the neurovascular coupling as well as evoked potential
amplitudes. Further research is needed to explore a simi-
lar protective role in other organ systems.
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